Understanding the Immune System's Role in Alzheimer's Disease and Aging
Antiviral response coupled with transposon derepression in Alzheimer's disease and aging
['FUNDING_R01'] · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · NIH-11103377
This work explores how the body's defense against viruses and certain genetic elements might contribute to Alzheimer's disease and the aging process.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-11103377 on ClinicalTrials.gov |
What this research studies
We are looking into how the immune system, specifically its antiviral responses, becomes active in the brains of people with Alzheimer's disease. We believe that certain genetic elements, called transposons, which are usually quiet, become active with age and in Alzheimer's, triggering this immune response. Our goal is to understand the molecular triggers for brain inflammation and how these processes are regulated. By understanding these connections, we hope to uncover new ways to help manage or prevent Alzheimer's disease.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but focuses on understanding the underlying biology of Alzheimer's disease and aging.
Not a fit: Patients seeking immediate treatment options or direct clinical intervention would not find direct benefit from this basic science investigation.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that target the immune system or genetic elements to slow down or prevent Alzheimer's disease progression.
How similar studies have performed: While the specific link between antiviral responses, transposon derepression, and Alzheimer's is a newer area, research into neuroinflammation and genetic factors in AD has shown promising directions.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CAO, WEI — UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
- Study coordinator: CAO, WEI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease